S&P 500 7,431.46 +0.50% NASDAQ 25,888.84 +0.31% DOW 51,202.26 +0.70% R2K 2,943.99 +0.79% VIX 16.75 -5.26% US 10Y 4.49 +0.54%
Next Bullish Trade
COO The Cooper Companies, Inc. NMS
$67.88 +0.37 (+0.55%)
Extended · +1.88σ Grade C

Price chart

Overlay: Click earnings ▲ markers for day-move details

Loading 1Y daily…

Financial overlay · last 12 quarters

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-04-30 $1.1B $-0.1B $-0.0B $0.1B -7.2% -2.9%
2026-01-31 $1.0B $0.1B $0.2B $0.2B 12.8% 20.8%
2025-10-31 $1.1B $0.1B $0.1B $0.1B 7.9% 13.2%
2025-07-31 $1.1B $0.1B $0.2B $0.2B 9.3% 16.6%
2025-04-30 $1.0B $0.1B $0.2B $0.0B 8.7% 18.4%

Earnings replay · last 20 reports

DateEPS actual EPS estSurprise
2026-06-04 1.21 1.09 +10.5%
2026-03-05 1.10 1.03 +7.0%
2025-12-04 1.15 1.11 +3.3%
2025-08-27 1.10 1.07 +3.0%
2025-05-29 0.96 0.93 +3.3%
2025-03-06 0.92 0.91 +0.9%
2024-12-05 1.04 1.00 +4.0%
2024-08-28 0.96 0.91 +5.4%
2024-05-30 0.85 0.83 +2.6%
2024-02-29 0.85 0.78 +8.5%
2023-12-07 0.87 0.87 -0.4%
2023-08-30 0.84 0.84 +0.3%
2023-06-01 0.77 0.76 +1.7%
2023-03-02 0.73 0.67 +7.5%
2022-12-08 0.69 0.78 -11.6%
2022-08-31 0.80 0.81 -1.2%
2022-06-02 0.81 0.86 -5.5%
2022-03-03 0.81 0.78 +4.2%
2021-12-02 0.82 0.84 -2.9%
2021-09-02 0.85 0.82 +3.6%

Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).

Peer comparison · Healthcare

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
COO $13B 57.5 13.6 3.1 17.9 1.6 65.6% 7.9% 3.20%
LLY $1,010B 40.3 25.5 14.0 28.9 32.4 82.8% 55.5% 169.9% 0.91%
UNH $371B 30.8 19.5 0.8 19.8 3.8 18.8% 2.0% 0.7% 4.77%
JNJ $580B 27.9 18.9 6.0 17.9 7.1 68.0% 9.9% -52.9% 2.16%
MRK $294B 33.5 12.4 4.5 11.4 6.4 76.7% 4.9% 4.78%
ABBV $402B 111.1 14.0 6.4 15.6 -60.5 72.0% 12.4% -46.2% 5.17%
PFE $149B 20.0 9.3 2.4 7.9 1.7 74.8% 5.4% -10.1% 8.29%
TMO $174B 25.8 17.2 3.9 19.0 3.3 40.9% 6.2% 11.3% 3.17%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Top institutional holders

Top-10 concentration: 44.92%

HolderShares% out
Blackrock Inc. 16,618,129 8.52%
Vanguard Capital Management LLC 12,718,829 6.52%
T. Rowe Price Investment Management, 9,060,177 4.65%
State Street Corporation 8,768,419 4.50%
Vanguard Portfolio Management LLC 8,721,331 4.47%
Capital World Investors 7,414,949 3.80%
Browning West Lp 6,979,529 3.58%
Kayne Anderson Rudnick Investment Ma 6,616,677 3.39%
Price (T.Rowe) Associates Inc 5,393,880 2.77%
Geode Capital Management, LLC 5,311,523 2.72%

Insider activity · 90d

0 buys / 0 sells · ratio 0.0 · Finnhub

  • Rosebrough Walter M Jr 0
  • Rosebrough Walter M Jr 832
  • Carbone Barbara 3,779
  • Carbone Barbara 0
  • Carbone Barbara 3,050
  • Rivas Maria 3,779
  • Rivas Maria 0
  • Rivas Maria 3,322
  • Jay Colleen 4,157
  • Jay Colleen 0

Analyst estimates

Finnhub
Low
$66.0
Mean
$80.57143
High
$92.0
Analysts
14
Recommendation distribution · period 2026-06-01
6
7
10
1
Revision trend (2026-03-01 → 2026-06-01): net 14 → 12 -2 (net = strong_buy+buy − sell−strong_sell)

SEC filings

FormFiled DescriptionAction
10-Q 2026-06-05 10-Q view ·
8-K 2026-06-04 8-K view ·
8-K 2026-05-04 8-K view ·
4 2026-04-21 PRIMARY DOCUMENT view ·
8-K 2026-04-08 8-K view ·
4 2026-04-06 PRIMARY DOCUMENT view ·
4 2026-04-06 PRIMARY DOCUMENT view ·
4 2026-04-06 PRIMARY DOCUMENT view ·
4 2026-04-06 PRIMARY DOCUMENT view ·
4 2026-04-06 PRIMARY DOCUMENT view ·
4 2026-04-06 PRIMARY DOCUMENT view ·
4 2026-04-06 PRIMARY DOCUMENT view ·
4 2026-04-06 PRIMARY DOCUMENT view ·
10-Q 2026-03-06 10-Q view ·
8-K 2026-03-05 8-K view ·
DEF 14A 2026-02-24 DEF 14A view ·
8-K 2026-02-04 8-K view ·
4 2026-01-14 PRIMARY DOCUMENT view ·
4 2026-01-12 PRIMARY DOCUMENT view ·
4 2026-01-12 PRIMARY DOCUMENT view ·
4 2026-01-12 PRIMARY DOCUMENT view ·
4 2026-01-12 PRIMARY DOCUMENT view ·
4 2026-01-12 PRIMARY DOCUMENT view ·
8-K 2025-12-23 8-K view ·
4 2025-12-23 PRIMARY DOCUMENT view ·
4 2025-12-19 PRIMARY DOCUMENT view ·
4 2025-12-17 PRIMARY DOCUMENT view ·
4 2025-12-16 PRIMARY DOCUMENT view ·
4 2025-12-16 PRIMARY DOCUMENT view ·
4 2025-12-15 PRIMARY DOCUMENT view ·
8-K 2025-12-12 8-K view ·
4 2025-12-11 PRIMARY DOCUMENT view ·
4 2025-12-11 PRIMARY DOCUMENT view ·
4 2025-12-11 PRIMARY DOCUMENT view ·
4 2025-12-11 PRIMARY DOCUMENT view ·
4 2025-12-11 PRIMARY DOCUMENT view ·
10-K 2025-12-05 10-K view ·
8-K 2025-12-04 8-K view ·
4 2025-09-29 PRIMARY DOCUMENT view ·
4 2025-09-05 PRIMARY DOCUMENT view ·
4 2025-09-05 PRIMARY DOCUMENT view ·
4 2025-09-02 PRIMARY DOCUMENT view ·
4 2025-09-02 PRIMARY DOCUMENT view ·
10-Q 2025-08-28 10-Q view ·
8-K 2025-08-27 8-K view ·
10-Q 2025-05-30 10-Q view ·
8-K 2025-05-29 8-K view ·
4 2025-05-05 PRIMARY DOCUMENT view ·
8-K 2025-04-30 8-K view ·
4 2025-04-03 PRIMARY DOCUMENT view ·
4 2025-04-03 PRIMARY DOCUMENT view ·
4 2025-04-03 PRIMARY DOCUMENT view ·
4 2025-04-03 PRIMARY DOCUMENT view ·
4 2025-04-03 PRIMARY DOCUMENT view ·
4 2025-04-03 PRIMARY DOCUMENT view ·
4 2025-04-03 PRIMARY DOCUMENT view ·
4 2025-04-03 PRIMARY DOCUMENT view ·
8-K 2025-04-02 8-K view ·
10-Q 2025-03-07 10-Q view ·
8-K 2025-03-06 8-K view ·

About

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.